Patents Represented by Attorney, Agent or Law Firm Cathy A. Kodroff
  • Patent number: 6271035
    Abstract: A rapid fluorescence staining method for facilitating flow cytometry analysis of reticulocytes is described. The method comprises contacting cells with a cocktail containing a detergent, sphering agent, and a cell impermeable dye, such as TO-PRO-3, for about one minute. Advantageously, the inventors have found that the cocktail permits the dye to penetrate the cell membrane rapidly.
    Type: Grant
    Filed: October 20, 1998
    Date of Patent: August 7, 2001
    Assignee: Coulter International Corp.
    Inventors: Chiranjit Deka, Kristie M. Gordon, Ravinder Gupta, Allan Horton
  • Patent number: 6235540
    Abstract: A semiconductor nanoparticle for use in analysis of biological samples is described. This semiconductor nanoparticle is composed of an aminodextran which is bound to at least one nanoparticle of the formula (X Y)n wherein X is selected from the group comprising Cd2+, Hg2+, and Zn2+ and combinations thereof; and Y is selected from the group comprising S2−, Se2− and Te2− and combinations thereof; and n=approximately 50 to 1000. Also provided are methods of making these semiconductor nanoparticles and methods of making conjugates composed of these semiconductor nanoparticles linked to ligands. Also described are uses for the conjugates in a variety of biological assays.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: May 22, 2001
    Assignee: Coulter International Corp.
    Inventors: Olavi Siiman, Egon Matijevic, Ivan Sondi
  • Patent number: 5945291
    Abstract: The present invention provides a method for distinguishing between viable, early apoptotic, late apoptotic and necrotic cells utilizing multi-color immunofluorescence.
    Type: Grant
    Filed: November 10, 1997
    Date of Patent: August 31, 1999
    Assignee: Coulter International Corp.
    Inventors: Wade E. Bolton, Steven K. Koester
  • Patent number: 5861311
    Abstract: The invention describes the preparation of preserved, non-infectious control cells. The control cells are prepared by modification, activation or otherwise changing selected normal leukocyte cells, tissue culture cells or zenogenic transplants in immunosuppressed animals to have characteristics of abnormal cells or by the addition of cells from an established cell line, which has been similarly modified or activated, to a normal leukocyte population. The preferred method of preserving the control cells is by lyophilization using an isotonic 10% trehalose solution.
    Type: Grant
    Filed: July 29, 1996
    Date of Patent: January 19, 1999
    Assignee: Coulter Corporation
    Inventors: John A. Maples, Patricia A. Roth, Melissa J. Stiglitz